Adverse Event Risk Up for >90 Days Versus >30 Days of Corticosteroids for Eczema
WEDNESDAY, July 24, 2024 (HealthDay News) — Use of oral corticosteroids for >90 days...
Read More
Pharmacy
Older Adult Co-Use of CYP2D6-Metabolized Opioids and CYP2D6-Inhibiting Antidepressants Worsens Pain and Increases Risk of Opioid-Related Adverse Events
For older nursing home (NH) residents, use of CYP2D6-metabolized opioids concomitantly with...
Read More
Digoxin, Beta-Blockers Have Equivalent Effects on Heart Rate in A-Fib
TUESDAY, July 23, 2024 (HealthDay News) — For patients with atrial fibrillation, digoxin and...
Read More
Long-Term Sulfonylurea Use Tied to Impaired Awareness of Hypoglycemia
TUESDAY, July 23, 2024 (HealthDay News) — The prevalence of impaired awareness of...
Read More
Neuromuscular Training Cuts Onset of Chemo-Induced Peripheral Neuropathy
MONDAY, July 22, 2024 (HealthDay News) — Neuromuscular training reduces the onset of...
Read More
2011 to 2023 Saw Increase in New GLP-1 Receptor Agonist Prescriptions
MONDAY, July 22, 2024 (HealthDay News) — From 2011 to 2023, there was an increase in new...
Read More
Aging Into Medicare Tied to Higher Drug Costs for People With Diabetes
WEDNESDAY, July 17, 2024 (HealthDay News) — As people with diabetes age into Medicare, they...
Read More
Extended-Release Oral Ketamine Effective for Treatment-Resistant Depression
WEDNESDAY, July 17, 2024 (HealthDay News) — For patients with treatment-resistant...
Read More
Ofatumumab Effective for MS Across Racial, Ethnic Subgroups
WEDNESDAY, July 17, 2024 (HealthDay News) — For patients with relapsing multiple sclerosis...
Read More
Risankizumab Noninferior, Superior to Ustekinumab for Crohn Disease
WEDNESDAY, July 17, 2024 (HealthDay News) — For patients with moderate-to-severe Crohn...
Read More
Acute Pain Opioid Consumption During 2 Weeks Post-ED Discharge Low, Varies by Pain Condition
For patients presenting with acute pain, the quantity of opioids consumed during two weeks after...
Read More
Suicidal Ideation, Behaviors Not Increased With GLP-1 RAs for Seniors With T2D
TUESDAY, July 16, 2024 (HealthDay News) — For older adults with type 2 diabetes (T2D), use...
Read More
Self-Imposed Use Cessation Dates Tied to Ophthalmic Drop Waste
TUESDAY, July 16, 2024 (HealthDay News) — Self-imposed use cessation dates (SUCD) for...
Read More
Benzodiazepines Not Tied to Higher Dementia Risk in Older Adults
TUESDAY, July 16, 2024 (HealthDay News) — Use of benzodiazepines is not associated with...
Read More
Direct CGRP Inhibition Cuts Acne, Rosacea in Patients With Migraine
TUESDAY, July 16, 2024 (HealthDay News) — For patients experiencing migraine, direct...
Read More
Metformin, SGLT2 Inhibitors Exhibit Significantly Lower Dementia Risk
MONDAY, July 15, 2024 (HealthDay News) — Compared with other antidiabetic classes, metformin...
Read More
GLP-1 RAs May Reduce Risk for Some Obesity-Linked Cancers Versus Insulin in T2D
THURSDAY, July 11, 2024 (HealthDay News) — For patients with type 2 diabetes (T2D),...
Read More
FDA Approves Zoryve for Atopic Dermatitis
THURSDAY, July 11, 2024 (HealthDay News) — The U.S. Food and Drug Administration has...
Read More
Most Children With Conjunctivitis Have Rx for Topical Antibiotics Filled
WEDNESDAY, July 10, 2024 (HealthDay News) — More than two-thirds of children with...
Read More
Study Looks at Impact of Incentivizing Smoking Cessation in Addition to Usual Care
WEDNESDAY, July 10, 2024 (HealthDay News) — Incentivizing smoking cessation increases...
Read More